Health Robotics Announces IV Station (TM pending).

Health Robotics, the worldwide leader in robotic automation of patient-specific IV Admixtures has announced the IV Station (TM Pending), a new IV automation solution.

Health Robotics has announced on 7th June, the launch of a modular, patient-specific Intra-Venous (IV) Automation Robot. It is used for non-hazardous drug preparation, compounding and dispensing in central pharmacy locations, satellite pharmacies and even patient care workplaces.

IV Station (TM Pending) is aimed at helping global health care providers deliver rapid, cost-effective and safer IV doses to their patients by addressing medication errors, sterility, accuracy and waste problems in the preparation, compounding and dispensing of IV Admixtures.

"While many companies have recognized the life-critical importance of IV safety, all patient-specific automation solutions up until now have focused on the prescription and administration steps of the medication delivery process with products such as Electronic Prescription and Smart Infusion Pumps," said Werner Rainer, CEO of health robotics.

IV Station (TM Pending) is the first patient-specific automation solution in the world that focuses on the preparation and compounding step of the life-critical process of IV Admixtures, where medication errors are arguably more critical given the inherent difficulty in their detection.

Beyond its patient safety benefits, IV Station (TM Pending) will address the waste problems of the current pharmacy process of Batch IVs [IVs that are not tailored to a specific patient clinical condition and therapy].

Health Robotics is accredited with the award-winning, world-leading, patient-specific chemotherapy IV robot, CytoCare(TM).

In the critical area of cancerdefine care, healthcare providers are experiencing a growing pressure to improve patient safety and decrease operators’ risk, while at the same time working more efficiently and containing costs.

CytoCare directly addressed these challenges, automating the dangerous and error prone preparation of cytostatic infusions, safely, accurately, efficiently and reliably. Such is expected of the new IV station too, which is to complement the CytoCare station.